Skip to main content
. 2014 Dec 8;2014(12):CD010590. doi: 10.1002/14651858.CD010590.pub2

Figure 5.

Figure 5

Networks of the treatment efficacy and safety of ESA drugs in the treatment of anaemia in chronic kidney disease. Values lower than 1 favour the active treatment in the comparison